Defects in cGMP-PKG pathway contribute to impaired NO-dependent responses in hepatic stellate cells upon activation

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 290, Issue 3, 2006, Pages

  Perri, Roman E ^a   Langer, Daniel A ^a   Chatterjee, Suvro ^a   Gibbons, Simon J ^a   Gadgil, Jay ^a   Cao, Sheng ^a   Farrugia, Gianrico ^a   Shah, Vijay H ^a  

^a MAYO CLINIC   (United States)

Author keywords

Guanylate cyclase; Protein kinase G

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; 8 BROMO CYCLIC GMP; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANYLATE CYCLASE INHIBITOR; NITRIC OXIDE DONOR; 1,1 DIETHYL 2 HYDROXY 2 NITROSOHYDRAZINE; 1,1-DIETHYL-2-HYDROXY-2-NITROSOHYDRAZINE; 1H (1,2,4)OXADIAZOLO(4,3 A)QUINOXALIN 1 ONE; 1H-(1,2,4)OXADIAZOLO(4,3-A)QUINOXALIN-1-ONE; 8-BROMOCYCLIC GMP; DRUG DERIVATIVE; HYDRAZINE DERIVATIVE; NITRIC OXIDE; NITROGEN OXIDE; OXADIAZOLE DERIVATIVE; QUINOXALINE DERIVATIVE;

ADENOVIRUS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CALCIUM CELL LEVEL; CELL ACTIVATION; CONTROLLED STUDY; DOWNSTREAM PROCESSING; GENE TARGETING; LIVER CELL; MALE; NITROSYLATION; NONHUMAN; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION; STELLATE CELL; ANIMAL; CALCIUM SIGNALING; CELL CULTURE; CELL LINE; CYTOLOGY; DRUG EFFECT; GENETIC TRANSDUCTION; GENETICS; HUMAN; LIVER; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADENOVIRIDAE; ANIMALS; CALCIUM SIGNALING; CELL LINE; CELLS, CULTURED; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; HUMANS; HYDRAZINES; HYPERTENSION, PORTAL; LIVER; MALE; NITRIC OXIDE; NITROGEN OXIDES; OXADIAZOLES; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; TRANSDUCTION, GENETIC;

EID: 33644974809     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00297.2005     Document Type: Article

References (38)

1. Angelico M, Carli L, Piat C, Gentile S, and Capocaccia L. Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis. Gastroenterology 113: 1632-1639, 1997.
2. Bolotina V, Najibi S, Palacino J, Pagano P, and Cohen R. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368: 850-853, 1994.
3. Bosch J, Abraldes J, and Groszmann R. Current management of portal hypertension. J Hepatol 38: S54-S68, 2003.
4. Browner NC, Dey NB, Bloch KD, and Lincoln TM. Regulation of cGMP-dependent protein kinase expression by soluble guanylyl cyclase in vascular smooth muscle cells. J Biol Chem 279: 46631-46636, 2004.
5. Clemens M. Nitric oxide in liver injury. Hepatology 30: 1-5, 1999.
6. Dudenhoefer A, Loureiro-Silva M, Cadelina G, Gupta T, and Groszmann R. Bioactivation of nitroglycerin and vasomotor response to nitric oxide are impaired in cirrhotic rat livers. Hepatology 36: 381-385, 2002.
7. Failli P, DeFranco R, Caligiuri A, Gentilini A, Romanelli R, Marra F, Batignani G, Guerra C, Laffi G, Gentilini P, and Pinzani M. Nitrova-sodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells. Gastroenterology 119: 479-492, 2000.
8. Garcia-Cardena G, Fan R, Shah V, Sorrentino R, Cirino G, Papapetropoulos A, and Sessa WC. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 392: 821-824, 1998.
9. + channels that modulate the effects of endothelin-1 and nitric oxide. J Hepatol 35: 739-748, 2001.
10. Gow A, Chen Q, Hess D, Day B, Ischiropoulos H, and Stamler J. Basal and stimulated protein S-nitrosylation in multiple cell types and tissues. J Biol Chem 277: 9637-9640, 2002.
11. Gupta T, Toruner M, Chung M, and Groszmann R. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats. Hepatology 28: 926-931, 1998.
12. Hendrickson H, Chatterjee S, Cao S, Morales Ruiz M, Sessa W, and Shah V. Influence of caveolin on constitutively activated recombinant eNOS: insights into eNOS dysfunction in BDL rat liver. Am J Physiol Gastrointest Liver Physiol 285: G652-G660, 2003.
13. Jaffrey S, Erdjument-Bromage H, Ferris C, Tempst P, and Snyder S. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat Cell Biol 3: 193-197, 2001.
14. Kaneda K, Ekataksin W, Sogawa M, Matsumura A, Cho A, and Kawada N. Endothelin-1-induced vasoconstriction causes a significant increase in portal pressure of rat liver: localized constrictive effect on the distal segment of preterminal portal venules as revealed by light and electron microscopy and serial reconstruction. Hepatology 27: 735-747, 1998.
15. Kawada N, Tran-Thi TA, Klein H, and Decker K. The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur J Biochem 213: 815-823, 1993.
16. Kawasaki K, Smith RJ, Hsieh C, Sun J, Chao J, and Liao J. Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis. Mol Biol Cell 23: 5726-5737, 2003.
17. Lee J, Decker N, Chatterjee S, Yao J, Friedman S, and Shah V. Mechanisms of nitric oxide interplay with Rho GTPase family members in modulation of actin membrane dynamics in pericytes and fibroblasts. Am J Pathol 166: 1861-1870, 2005.
18. 2+ channels through a nitric oxide-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 288: G7-G14, 2005.
19. Lincoln T, Dey N, and Sellak H. cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression. J Appl Physiol 91: 1421-1430, 2001.
20. Loureiro-Silva M, Iwakiri Y, Abraldes J, Haq O, and Groszmann R. Phosphodiesterase-5 (PDE-5) is up-regulated in cirrhotic rat livers; potential role for PDE-5 inhibitors in reducing the increased intrahepatic vascular tone in cirrhosis (Abstract). Hepatology 40: 271A, 2004.
21. Nozik-Grayck E, McMahon T, Huang Y, Dieterle C, Stamler J, and Piantadosi C. Pulmonary vasoconstriction by serotonin is inhibited by S- nitrosoglutathione. Am J Physiol Lung Cell Mol Physiol 282: L1057-L1065, 2002.
22. Pinzani M, Failli P, Ruocco C, Casini A, Milani S, Baldi E, Giotti A, and Gentilini P. Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients. J Clin Invest 90: 642-646, 1992.
23. Rockey D and Shah V. Nitric oxide and the liver. Hepatology 39: 250-257, 2004.
24. Rockey DC. The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide. Hepatology 25: 2-5, 1997.
25. Rockey DC and Chung JJ. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension. Gastroenterology 114: 344-351, 1998.
26. Rockey DC, Housset CN, and Friedman SL. Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo. J Clin Invest 92: 1795-1804, 1993.
27. Rockey DC and Weisiger RA. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance. Hepatology 24: 233-240, 1996.
28. Sarela A, Mihaimeed F, Batten J, Davidson B, and Mathie R. Hepatic and splanchnic nitric oxide activity in patients with cirrhosis. Gut 44: 749-753, 1999.
29. Shah V, Garcia-Cardena G, Sessa W, and Groszmann R. The hepatic circulation in health and disease: report of a single-topic symposium. Hepatology 27: 279-288, 1998.
30. Shah V, Haddad F, Garcia-Cardena G, Frangos J, Mennone A, Groszmann R, and Sessa W. Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of hepatic resistance. J Clin Invest 100: 2923-2930, 1997.
31. Shah V, Toruner M, Haddad F, Cadelina G, Papapetropoulos A, Sessa W, and Groszmann R. Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental liver cirrhosis. Gastroenterology 117: 1222-1228, 1999.
32. Stamler J, Lamas S, and Fang F. Nitrosylation: the prototypic redox-based signaling mechanism. Cell 106: 675-683, 2001.
33. Stamler J, Simon D, Osborne J, Mullins M, Jaraki O, Michel T, Singel D, and Loscalzo J. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA 89: 444-448, 1992.
34. Torok N, Higuchi H, Bronk S, and Gores G. Nitric oxide inhibits apoptosis downstream of cytochrome c release by nitrosylating caspase 9. Cancer Res 62: 1648-1653, 2002.
35. 2+-sensitive ion channels. Cell Calcium 34: 211-229, 2003.
36. Wu L, Cao K, Lu Y, and Wang R. Different mechanisms underlying the stimulation of KCa channels by nitric oxide and carbon monoxide. J Clin Invest 110: 691-700, 2002.
37. Xu L, Hui A, Albanis E, Arther M, O'Byrne S, Blaner W, Mukherjee P, Friedman S, and Eng F. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 54: 142-151, 2005.
38. Zhang J, Pegoli W, and Clemens M. Endothelin-1 induces direct constriction of hepatic sinusoids. Am J Physiol Gastrointest Liver Physiol 266: G624-G632, 1994.